Get started
Author

Ameer Basta

Observed names: Ameer S Basta, Ameer S. Basta, Ameer Sherif Basta, Basta, Ameer
ORCID: 0000-0002-7238-6454
Observed ORCID: 0000-0002-7238-6454
OpenAlex ID: A5043540254
Clonal hematopoiesis in older patients with breast cancer receiving chemotherapy
2023 · Christina Mayerhofer, Mina S Sedrak, et al. · JNCI Journal of the National Cancer Institute · 35
PDF
Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS)
2025 · Romualdo Barroso-Sousa, Jorge Gomez Tejeda Zanudo, et al. · Nature Communications · 15
PDF
‘ADVANCE’ (a pilot trial) ADjuVANt chemotherapy in the elderly: Developing and evaluating lower-toxicity chemotherapy options for older patients with breast cancer
2022 · Rachel A. Freedman, Tianyu Li, et al. · Journal of Geriatric Oncology · 12
Pre-Surgical Education and Discharge Planning for Head and Neck Cancer: A Qualitative Study of Patient and Caregiver Perspectives
2025 · Ameer Basta, Marian Mikhael, et al. · Cancer Control · 4
Suicide Risk Screening for Head and Neck Cancer Patients: An Implementation Study
2024 · Bhargav Kansara, Ameer Basta, et al. · Applied Clinical Informatics · 3
PDF
Benchmarking clinical reasoning and accuracy of large language models on breast oncology multiple-choice questions.
2025 · Roupen Odabashian, Ameer Sherif Basta, et al. · Journal of Clinical Oncology · 1
Optimizing presurgical education for patients with head and neck cancer receiving laryngectomy and free flap surgery: A qualitative study
2024 · Marian Mikhael, Bhargav Kansara, et al. · Head & Neck · 1
PDF
Pre-Surgical Education and Discharge Planning for Head and Neck Cancer: A Qualitative Study of Patient and Caregiver Perspectives.
2026 · Hume, Emma, Mikhael, Marian, et al. · UNC Libraries
A Cohort Study of the Effectiveness of Trastuzumab Deruxtecan for Treating Metastatic Progressive HER2-Positive Breast Cancer
2026 · Ameer Basta, Kyle Lien, et al. · Clinical Breast Cancer
A Real-World Single-Center Cohort Study on the Tolerability of Trastuzumab Deruxtecan for HER2+ Metastatic Breast Cancer
2025 · Ameer Basta, Kyle Lien, et al. · Oncology
Abstract P2-08-04: A Cohort Study of the effectiveness and tolerability of Trastuzumab Deruxtecan For The Treatment of Metastatic or Locally Advanced HER2-positive Breast Cancer
2025 · Ameer Basta, Kyle Lien, et al. · Clinical Cancer Research
Author response for "Pre-Surgical Education and Discharge Planning for Head and Neck Cancer: A Qualitative Study of Patient and Caregiver Perspectives"
2025 · Ameer Basta, Marian Mikhael, et al.
Abstract PO2-27-12: Genomic determinants of benefit to nivolumab (NIVO) plus low dose ipilimumab (IPI) among patients (pts) with hypermutated HER2-negative metastatic breast cancer (MBC): results of NIMBUS trial
2024 · Romualdo Barroso-Sousa, Tyler Chinsky, et al. · Cancer Research
Abstract LB_B24: Validating novel therapeutic antibodies for targeting head & neck squamous cell malignancies
2023 · Ameer S Basta, Marc de la Roche · Molecular Cancer Therapeutics
Works count: 14
Citation count: 71
H-index: 4
I10-index: 3
Year
Topic
Type